Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQ93K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,691
Award facts
- Contract value 100% obligated
- $13,690.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units, with a ceiling value of $13,690.50 and a firm fixed-price structure. This non-set-aside, competitively awarded contract represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 29, 2025.
As one of the nation's largest pharmaceutical distributors, AmerisourceBergen serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's DLA Troop Support Medical contract enables the supply of a comprehensive range of pharmaceuticals and medical products—including specialty medications, vaccines, and medical devices across multiple therapeutic domains—to support military healthcare programs globally. This particular delivery order for Xeljanz XR, a treatment for rheumatoid arthritis and other autoimmune conditions, exemplifies the company's ongoing role in furnishing brand-name pharmaceutical products essential to federal beneficiary populations.
Quick answers
Who was awarded contract SPE2DB25FQ93K?
SPE2DB25FQ93K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FQ93K worth?
The government has obligated $13,691 on SPE2DB25FQ93K.
Is contract SPE2DB25FQ93K an order under another contract?
Yes. SPE2DB25FQ93K is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ93K competed?
The extent of competition for SPE2DB25FQ93K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award